Exosome-Total-Isolation-Chip (ExoTIC) device for isolation of exosome-based biomarkers

Patent metadata

Field	Value
Publication number	US-11073511-B2
Application number	US-201716073577-A
Country	US
Kind code	B2
Filing date	Feb 1, 2017
Priority date	Feb 1, 2016
Publication date	Jul 27, 2021
Grant date	Jul 27, 2021

Abstract

A device (“the ExoTIC device”) for the isolation of extracellular vesicles from an extracellular vesicle-containing sample in which the sample is flowed through a membrane in a flow chamber to capture and purify the extracellular vesicles on the membrane. The extracellular vesicles may be washed and collected and utilized in any one of a number of ways including, but not limited to, identifying biomarkers of a disease, identifying the presence of a biomarker in a patient to determine whether a patient has a disease, and therapeutically treating existing diseases by re-introducing the extracellular vesicles, potentially modified, back into a body.

First claim

What is claimed is:

1. A method of processing an extracellular vesicle-containing sample using a device for extracellular vesicle isolation, the method comprising:
flowing the extracellular vesicle-containing sample through a flow chamber of the device for extracellular vesicle isolation under an applied fluid pressure, the device having an inlet and an outlet which are placed in fluid communication with one another via the flow chamber and the device further having a membrane through which the extracellular vesicle-containing sample must flow as the extracellular vesicle-containing sample flows from the inlet to the outlet;
isolating extracellular vesicles from the extracellular vesicle-containing sample on the membrane with the membrane collecting at least some of the extracellular vesicles thereon while permitting a remainder of the extracellular vesicle-containing sample to flow therethrough towards the outlet.

2. The method of claim 1 , wherein the extracellular vesicles are exosomes.

3. The method of claim 1 , wherein the extracellular vesicle-containing sample is selected from the group consisting of culture media, blood, plasma, serum, urine, saliva, lavage, and ascitic fluid.

4. The method of claim 1 , wherein the step of flowing involves injecting the extracellular vesicle-containing sample into the inlet using a syringe or syringe pump.

5. The method of claim 1 , wherein the membrane has an average pore diameter below 200 nm.

6. The method of claim 1 , wherein the device further includes at least one supportive backing layer between the membrane and the outlet to assist the membrane in retaining form under the applied fluid pressure.

7. The method of claim 1 , wherein the step of flowing the extracellular vesicle-containing sample through a flow chamber of the device for extracellular vesicle isolation under an applied fluid pressure involves rotating the device to alter an orientation of the inlet relative to the outlet to facilitate collection of the extracellular vesicles isolated on the membrane.

8. The method of claim 1 , further comprising the step of washing the extracellular vesicles collected on the membrane by flowing a washing fluid over the extracellular vesicles collected on the membrane.

9. The method of claim 1 , further comprising the step of collecting the extracellular vesicles from the membrane.

10. The method of claim 9 , further comprising evaluating the extracellular vesicles collected from the membrane.

11. The method of claim 10 , wherein the step of evaluating the extracellular vesicles collected from the membrane involves aggregating a plurality of collected extracellular vesicles from extracellular vesicles-containing samples of different patients to identify shared biomarkers across the plurality of collected extracellular vesicles in which the shared biomarkers are indicative of a shared disease of the patients.

12. The method of claim 10 , wherein the step of evaluating the extracellular vesicles collected from the membrane involves comparing a profile of the extracellular vesicles collected from the membrane to a known profile associated with a disease of a patient to diagnose a patient with a disease.

13. The method of claim 12 , wherein the step of comparing the profile of the extracellular vesicles collected from the membrane to a known profile associated with a disease of a patient to diagnose a patient with a disease includes identifying a stage or severity of the disease.

14. The method of claim 9 , wherein the step of evaluating the extracellular vesicles collected from the membrane includes determining a drug responses of a patient to a drug and monitoring resistance of the extracellular vesicles over time.

15. The method of claim 1 , wherein the method involves placing several devices for extracellular vesicle isolation in series with one another, connecting the outlet of one of the devices to the inlet of another one of the devices to form a modular device, in which each of the several devices for extracellular vesicle isolation has a membrane with a different porosity and then flowing the extracellular vesicles-containing sample through the modular device thereby resulting in size-based separation of the extracellular vesicles.

16. The method of claim 1 , wherein the extracellular vesicles collected on the membrane are subsequently utilized in a therapeutic treatment.

Assignees

• Univ Leland Stanford Junior

Inventors

• Liu Fei
• Demirci Utkan
• Gambhir Sanjiv Sam
• Nair Viswam S

Classifications

• G01N33/50 Primary

  Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q) · CPC title

• G01N33/5005

  involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title

• G01N33/5091 Primary

  for testing the pathological state of an organism · CPC title

• B01L3/502761

  specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules · CPC title

• B01L3/50273

  characterised by the means or forces applied to move the fluids · CPC title